Reports on the efforts of researchers to test prognostic indicators to identify breast cancer patients who will benefit from adjuvant therapy. Background on adjuvant therapy; Problems seen with the findings for bcl-2 in the breast cancer prognostic field; Widely used indicators seen for breast cancer; Inconsistency and lack of standardization seen in practice.